Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of a nine‐gene panel as a prognostic indicator for recurrence with muscle‐invasive bladder cancer

18 Mar 2019

Abstract excerpt

BACKGROUND AND OBJECTIVES: Bladder cancer is one of the most common and highly recurrent cancers worldwide. Recurrence-associated genes may potentially predict cancer recurrence. We aimed to construct a recurrence-associated gene panel to improve the prognostic prediction of bladder cancer. METHODS: Based on DNA sequencing and clinical data from the TCGA-BLCA project, we identified 10 potential driver genes...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Cancer-related molecular mechanisms research
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30887516
DOI: 10.1002/jso.25446

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of a nine‐gene panel as a prognostic indicator for recurrence with muscle‐invasive bladder cancerPMID 30887516Read ↗

Multi-Omics analysis identifies a lncRNA-related prognostic signature to predict bladder cancer recurrence.Semantic proximity Read ↗

Genome-wide Meta-analysis Identifies Novel Genes Associated with Recurrence and Progression in Non–muscle-invasive Bladder CancerSemantic proximity Read ↗

Novel variants in MLL confer to bladder cancer recurrence identified by whole-exome sequencing.Semantic proximity Read ↗

Comprehensive genome-wide association study into multiple recurrence and progression risk in non-muscle invasive bladder cancer.Semantic proximity Read ↗

Novel Gene expression-based Risk Stratification tool predicts recurrence in Non-muscle invasive Bladder cancerSemantic proximity Read ↗

Long non-coding RNAs to predict postoperative recurrence in muscle-invasive bladder cancer and to develop a new molecular classification systemSemantic proximity Read ↗

An eight-long non-coding RNA signature as a candidate prognostic biomarker for bladder cancerSemantic proximity Read ↗

Preoperative fluorescence in situ hybridization analysis as a predictor of tumor recurrence in patients with non-muscle invasive bladder cancer: a bi-institutional studySemantic proximity Read ↗

Prognostic Factors of Non-Muscle Invasive Bladder Cancer: A Study Based on Next-generation SequencingSemantic proximity Read ↗

Update on bladder cancer molecular subtypesSemantic proximity Read ↗

A methylation assay for the detection of non‐muscle‐invasive bladder cancer (NMIBC) recurrences in voided urineSemantic proximity Read ↗

Development and Validation of a Prognostic Nomogram Model for Recurrence of Non-Muscle Invasive Bladder CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.